James Corbett - 05 Jun 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: CEO, Director
Signature: /s/ Donna Shiroma
Issuer symbol: RCEL
Transactions as of: 05 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2024, 19:02:32 UTC
Previous filing: 27 Dec 2023
Next filing: 05 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+350,000		$0.000000	350,000	05 Jun 2024	Common Stock	350,000	$12.64	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to Mr. Corbett's Employment Agreement, he is eligible for annual equity grants. On January 3, 2024, the Board of Directors approved a grant of 350,000 options to acquire 350,000 shares of Common Stock of the Company to Mr. Corbett, with an effective grant date of January 3, 2024 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 3, 2024 of $12.64. The grant was subject to the approval of the Company's stockholders, which was obtained on June 5, 2024.
F2	These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of January 3, 2024.

Content

Pursuant to Mr. Corbett's Employment Agreement, he is eligible for annual equity grants. On January 3, 2024, the Board of Directors approved a grant of 350,000 options to acquire 350,000 shares of Common Stock of the Company to Mr. Corbett, with an effective grant date of January 3, 2024 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 3, 2024 of $12.64. The grant was subject to the approval of the Company's stockholders, which was obtained on June 5, 2024.

These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of January 3, 2024.